Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

New AI Tech Predicts Diagnostic Concordance For Melanoma, Proscia Says

Proscia
By Author Proscia | November 1, 2022

Proscia released study results on new artificial intelligence (AI) that predicts diagnostic agreement for melanoma, the deadliest form of skin cancer.

Read Full Article

Our website uses cookies. By using this site, you agree to its use of cookies.

Agree

Privacy Policy